共 50 条
- [23] Clinical Impact of Pre-Existing Autoantibodies in Patients With SCLC Treated With Immune Checkpoint Inhibitor: A Multicenter Prospective Observational Study JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (12):
- [26] Efficacy and Safety of Anlotinib for Elderly Patients with Previously Treated Extensive-Stage SCLC and the Prognostic Significance of Common Adverse Reactions CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 11133 - 11143
- [28] Comparison of the tumor immune microenvironment and checkpoint blockade biomarkers between stage III and IV non-small cell lung cancer Cancer Immunology, Immunotherapy, 2023, 72 : 339 - 350